Skip to content

Calculus completes four investments in July

Calculus has made four investments in July across sectors including medtech, software and technology. On 3 July Calculus closed investments in Arcis Biotechnology and Quai Administration Services. Arcis has developed a patent-protected platform technology which is seeking to improve the Molecular Diagnostics sector. Arcis’ technology allows the extraction of DNA and RNA from various sample types (human, … Continued

Arcis Biotechnology and Opentrons Sign Distribution Agreement

Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, today announced it has signed a commercial distribution agreement with Opentrons, the developer of affordable pipetting robots. The agreement allows Opentrons to directly distribute Arcis’ sample preparation kits to laboratories globally, providing scientists with a complete, accessible and automated solution for high throughput RNA/DNA preservation … Continued